Prostate cancer - biology of metastasis and its clinical implications

World Journal of Urology

Volumn 14, Issue 3, 1996, Pages 182-189

  Dong, J T ^a   Rinker Schaeffer, C W ^a   Ichikawa, T ^a   Barrett, J C ^a   Isaacs, J T ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CHROMOSOME 11; CHROMOSOME MAP; GENETICS; HUMAN; MALE; METASTASIS; MOLECULAR CLONING; PATHOPHYSIOLOGY; PROSTATE TUMOR; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CLONING, MOLECULAR; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS;

EID: 0029683131     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00186898     Document Type: Article

References (63)

1. Ainiot M (1990) Identification and analysis of cDNA clones encoding CD53. A panleukocyte antigen related to membrane transport proteins. J Immunol 145:4322-4325
2. Atkin NB, Baker MC (1985) Chromosome study of five cancers of the prostate. Hum Genet 70:359-364
3. Backer JM. Mendola CE, Kovesdi I, Fairhurst JL. O'Hara B, Eddy R Jr. Shows TB. Mathew S. Murty VV. Chaganti RS (1993) Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-I and NM23-2.Oncogene 8:497-502
4. Baker S.I. Fearon ER. Nigro JM. Hamilton SR. Preisinger AC. Jessup JM. van Tuinen P. Ledhetter DH. Barker DF. Nakamura Y ( 1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221
5. Bergerheim US. Kunimi K. Collins VP, Ekman P ( 1991 ) Deletion mapping of chromosomes 8, 10. and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 3:215-220
6. Bernstein SC. Weinberg RA (1985) Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Nat! Acad Sci USA 82: 1726-1730
7. Boueheix C. Benoit P, Frachet P. Billard M. Worthingion RE. Gagnon J. U/an G ( 1991 ) Molecular cloning of the CD9 antieen. A new family of cell surface proteins. J Biol Chem 266: U 7-122
8. Bova GS. Carter BS. Bussemakers MJ. Emi M. Fujiwara Y. Kyprianou N. Jacobs SC. Robinson JC. Epstein JI. Walsh PC. Isaacs WB (1993) Homozygous deletion and frequent alloue loss of chromosome 8q22 loci in human prostate cancer. Cancer Res 53 :3869-3873
9. Bradley MO. Kraynak AR. Storer RD. Gibbs JB ( 1986) Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc Natl Acad Sci USA 83:5277-5281
10. . Brodeur CM. Seeger RC. Schwab M. Varmus HE. Bishop JM ( 1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124
11. Bussemakers MJ, Moorselaar RJ van, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M. Debruyne FM. Schalken JA ( 1992) Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 52:2916-2922
12. Classon BJ, Williams AF, Willis AC. Seed B, Stamenkovic I (1989) The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 169:1497-1502
13. Dennis JW, Laferte S, Wagborne C, Brettman ML. Kerbel RS (1987) bl-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236:582-585
14. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barren JC (1995) KAIL a metastasis suppressor gene for prostate cancer on human chromosome 1 Iq 11.2. Science 268:884-886
15. Drickamer K, Taylor ME (1993) Biology of animal lectins. Annu Rev Cell Biol 9:237-264
16. Dunning WF (1963) Prostate cancer in the rat. Monogr Natl Cancer Inst 12:351-369
17. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987) Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830-837
18. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-rnediated cellcell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185
19. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Hinuma Y, Yoshie O (1992) Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-l)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol 66:1394-1401
20. Gaugitsch HW, Hofer E, Huber NE, Schnabl E, Baumruker T (1992) A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 21:377-383
21. Gil ML, Vita N, Lebel-Binay S, Miloux B, Chalon P, Kaghad M, Marchiol-Fournigault C, Conjeaud H, Caput D, Ferrara P, Fradelizi D, Quillet-Mary A (1992) A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated, killer-susceptible B lymphocyte line. Cloning and preliminary functional studies. J Immunol 148: 2826-2833
22. Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G (1985) Tumorigenic and metastatic properties of normal and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci USA 82:3698-3701
23. Griffin CA, McKeon C, Israel MA, Gegonne A, Ghysdeal J, Stehelin D, Douglass EC, Green AE, Emanuel BS (1986) Comparison of constitutional and tumor-associated 11 ;22 translocations: nonidentical breakpoints on chromosome 11 and 22. Proc Natl Acad Sci USA 83:6122-6126
24. Hakomori S-I (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52 : 257-331
25. Horejsi V, Vlcek C (1991) Novel structurally distinct family of leucocyte surface glycoproteins including CD9. CD37, CD53 and CD63. FEBS Lett 288: 1-4
26. Hotta H, ROSS AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H (1988) Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 48:2955-2962
27. Ichikawa T, Ichikawa Y, Isaacs JT (1991) Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res 51:3788-3792
28. Ichikawa T, Schalken JA, Ichikawa Y, Steinberg GD, Isaacs JT (1991) H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-Hras oncogene transfection. Prostate 18: 163-172
29. Ichikawa T, Ichikawa Y, Dong J. Hawkins AL, Griffin CA. Isaacs WB, Oshimura M, Barren JC, Isaacs JT (1992) Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 1 1. Cancer Res 52:3486-3490
30. Ichikawa T. Ichikawa Y, Isaacs JT (1992) Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells. Proc Natl Acad Sci USA 89:1607-1610
31. Ichikawa T. Nihei N. Suzuki H, Oshimura M, Emi M, Nakamura Y, Hayata I. Isaacs JT; Shimazaki J (1994) Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 54:2299-2302
32. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyaké M ( 1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J ExpMed 177:1231-1237
33. Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, Nishimura M, Hinuma Y, Yoshie O (1992) C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a few family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 149:2879-2886
34. Isaacs JT, Hukku B (1988) Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer. Prostate 13:165-188
35. Isaacs WB, Carter BS (1991) Genetic changes associated with prostate cancer in humans. Cancer Surv 11:15-24
36. Ishikawa M, Dennis JW, Kerbel RS (1988) Isolation and characterization of spontaneous wheat-germ-agglutinin-resistant human melanoma mutants displaying remarkable different metastatic profiles in nude mice. Cancer Res 48:655-670
37. Junien C, Heyningen V van (1990) Report of the Committee on the Genetic Constitution of Chromosome 11. Cytogenet Cell Genet 55:153-169
38. Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M (1989) Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinog 2:12-21
39. Kondoh M, Ueda M, Ichihashi M, Mishima Y (1993) Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res 3:241-245
40. Levy S, Nguyen VQ, Andria ML, Takahashi S (1991) Structure and membrane topology of TAPA-1. J Biol Chetn 266: 14597-14602
41. Liu E, Dollbaum C, Scott G, Rochlitz C, Benz C, Smith HS (1988) Molecular lesions involved in the progression of a human breast cancer. Oncogene 3:323-327
42. Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mitelman F (1988) Multiple structural chromosome rearrangements, including del(7q) and del(lOq), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108
43. Mareel MM, Behrens J, Birchmeier W, DeBruyne GK, Vleminckx K, Hoogewijs A, Fiers WC, Van Roy FM (1991) Downregulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 47:922-928
44. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ; Nieuwenhuis HK, Clevers HC (1991) CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J. Biol Chem 266: 3239-3245
45. Miyake M, Koyama M, Seno M, Ikeyama S (1992) Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174:1347-1354
46. Nelson DL, Ledbetter SA, Corbo L, Victoria MF, Ramirez-Solis R, Webster TD, Ledbetter DH, Caskey CT ( 1989) Alu poly-merase chain reaction: a method for rapid isolation of humanspecific sequences from complex DNA sources. Proc Natl Acad Sci USA 86:6686-6690
47. Nihei N, Ichikawa T, Kawato Y, Kuramochi H, Kugo H, Oshimura M, Kiilary AM, Rinker-Schaeffer CW, Barrett JC, Isaacs JT, Shimazaki J (1995) Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer 14:112-119
48. Oren R, Takahashi S, Doss C, Levy R, Levy S (1990) TAPA1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10:4007-4015
49. Oshimura M, Kogoh H, Koi M, Shimizu M, Yamada H, Satoh H, Barrett JC (1990) Transfer of a normal human chromosome 1 1 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42:135-142
50. Partin AW. Isaacs JT, Treiger B, Coffey DS (1988) Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harveyras oncogene. Cancer Res 48:6050-6053
51. Rinker-Schaeffer CW, Partin AW, Isaacs WB. Coffey DS, Isaacs JT (1994) Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25:249-265
52. Schalken JA, Ebeling SB, Isaacs JT, Treiger B, Bussemarkers MJ, Jong ME de. Van de Yen WJ (1988) Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res 48:2042-2046
53. Sharon N, Lis H (1989) Lectins as cell recognition molecules. Sciences 246:227-234
54. Steeg PS. Bevilacqua G, Kopper L. Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200-204
55. Takeichi M (1988) The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102:639-655
56. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455
57. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Heilman ÇA, Talmadge JE, Liotta LA (1985) NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5:259-262
58. Treiger B, Isaacs JT (1988) Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol 140: 1580-1586
59. Umbas R, Schalken JA, Aalders TW. Carter BS. Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109
60. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA (1994) Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929-3933
61. Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J. Hand P, Thor A, Schlom J ( 1986) Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314:133-137
62. Vleminckx K. Vakaet L Jr, Marcel M, Fiers W, Roy F van (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cell reveals an invasion suppressor role. Cell 66: 107-119
63. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ (1987) Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236: 175-180